KWILP
HALO icon

Kiwi Wealth Investments Limited Partnership’s Halozyme HALO Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,707
Closed -$823K – 233
2022
Q3 		$823K Hold
18,707
– – 0.06% 177
2022
Q2 		$823K Buy
+18,707
New +$809K 0.06% 177

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's HALO Position: Q4 2022 in Review

Kiwi Wealth Investments Limited Partnership sold out of Halozyme (HALO) in Q4 2022, closing a stake of 18,707 shares — an estimated $823K sold.

Kiwi Wealth Investments Limited Partnership first reported a position in HALO in Q2 2022 and held it in 2 quarters. The position peaked at $823K in Q3 2022. 423 funds tracked by Wall St. Rank hold HALO as of Q4 2022.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Halozyme position as of Q4 2022 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 18,707 Halozyme shares in Q4 2022, an estimated $823K.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Halozyme in Q2 2022 and held it in 2 quarters.
  • Kiwi Wealth Investments Limited Partnership's Halozyme position peaked at $823K in Q3 2022.
  • 423 funds tracked by Wall St. Rank held Halozyme as of Q4 2022.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q4 2022, filed 15 Feb 2023.